
Torrent Pharmaceuticals has announced the results for the quarter ended December. The company said that its profit in the third quarter of FY 2025 has increased by 13.5 percent to Rs 503 crore, which was Rs 443 crore in the same quarter a year ago. The company's income has increased to Rs 2,809 crore, which is an increase of 2.8 percent from Rs 2,732 crore in the same quarter a year ago.
The company's EBITDA has seen a growth of 5.2 percent, which stood at Rs 914 crore. A year ago in this quarter, the company had recorded an EBITDA of Rs 869 crore. The company's EBITDA margin stood at 32.5 percent, which was 31.8 percent in this quarter a year ago. Share performance The company's stock closed at Rs 3,248.90 on Friday with a decline of 0.46 percent. In the last one year, the company's share has seen an increase of 29.59 percent.